CryoLife gets $99,000 research grant:
This article was originally published in Clinica
Executive Summary
CryoLife (US) has been awarded a $99,000 Phase I innovative research grant from the US NIH for its bioengineered human implantable heart valve. CryoLife will conduct studies using a porcine heart valve collagen matrix that can be "seeded" with human cells with the goal of creating a non-immunogenic heart valve for application in human replacement surgery. CryoLife has received four previous NIH grants since 1991, totalling $284,000 in development funding.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.